↓ Skip to main content

PLOS

7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?

Overview of attention for article published in PLOS ONE, October 2011
Altmetric Badge

Mentioned by

blogs
1 blog

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
75 Mendeley
Title
7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?
Published in
PLOS ONE, October 2011
DOI 10.1371/journal.pone.0026190
Pubmed ID
Authors

Yoon Hong Choi, Mark Jit, Nigel Gay, Nick Andrews, Pauline A. Waight, Alessia Melegaro, Robert George, Elizabeth Miller

Abstract

The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national vaccination program in September 2006. Previous modelling assumed that the likely impact of PCV7 on invasive pneumococcal disease (IPD) would be similar to the US experience with PCV7. However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 3%
France 1 1%
Colombia 1 1%
Kenya 1 1%
Italy 1 1%
Unknown 69 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 27%
Student > Ph. D. Student 17 23%
Student > Master 10 13%
Student > Bachelor 5 7%
Professor 4 5%
Other 13 17%
Unknown 6 8%
Readers by discipline Count As %
Medicine and Dentistry 29 39%
Agricultural and Biological Sciences 13 17%
Mathematics 5 7%
Social Sciences 4 5%
Immunology and Microbiology 3 4%
Other 7 9%
Unknown 14 19%